Stents

09/05/2019

Cath Lab Digest talks with Erik G. Stilp, MD, FACC, RPVI, Ascension – Columbia St. Mary’s, Milwaukee, Wisconsin.

Cath Lab Digest talks with Erik G. St...

I hesitate to stent in the P2 and P3 segments of the popliteal, but the LifeStent Vascular Stent System (BD) is a nice option in those places, based off the level 1, rigorous ETAP trial data(1) (Endovascular Treatment of Atherosclerotic...

I hesitate to stent in the P2...

09/05/2019

Cath Lab Digest

Case Study

Laocoön’s Revenge: A Novel Non-Drug Eluting Two-Stent Strategy for Complex Bifurcation Intervention — Talking With the Operator

11/05/2018

Cath Lab Digest talks with Gautam Kumar, MD

Cath Lab Digest talks with Gautam Kum...

This was a very complex case where we had to deal with both a bifurcation and a chronic total occlusion (CTO) in a patient at high bleeding risk.

This was a very complex case...

11/05/2018

Cath Lab Digest

Case Study

Laocoön’s Revenge: A Novel Non-Drug Eluting Two-Stent Strategy for Complex Bifurcation Intervention — Talking With the Operator

11/05/2018

Cath Lab Digest talks with Gautam Kumar, MD

Cath Lab Digest talks with Gautam Kum...

This was a very complex case where we had to deal with both a bifurcation and a chronic total occlusion (CTO) in a patient at high bleeding risk.

This was a very complex case...

11/05/2018

Cath Lab Digest

Case Study

Laocoön’s Revenge: A Novel Non-Drug Eluting Two-Stent Strategy for Complex Bifurcation Intervention

11/05/2018

Frank E. Corrigan III,¹MD, and Gautam Kumar,^2,3 MD

Frank E. Corrigan III,1 MD, and Gauta...

We present this case of complex PCI of a subacute/chronic total circumflex occlusion at a Medina 1,1,1 bifurcation using a novel “Laocoön strategy” — a two-stent technique utilizing non-DES systems (Tryton bifurcation stent, Tryton Medical,...

We present this case of complex...

11/05/2018

Cath Lab Digest

Case Study

Laocoön’s Revenge: A Novel Non-Drug Eluting Two-Stent Strategy for Complex Bifurcation Intervention

11/05/2018

Frank E. Corrigan III,¹MD, and Gautam Kumar,^2,3 MD

Frank E. Corrigan III,1 MD, and Gauta...

We present this case of complex...

11/05/2018

Cath Lab Digest

News

News: Boston Scientific Receives U.S. FDA Approval for the Eluvia Drug-Eluting Vascular Stent System

10/03/2018

The FDA’s approval is based on findings from the IMPERIAL trial, in which the Eluvia stent demonstrated superior results in the first superficial femoral artery head-to-head drug-eluting stent trial.

The FDA’s approval is based on...

10/03/2018

Cath Lab Digest

Case Report

In-Stent Neoatherosclerosis as a Cause for High-Risk Non ST-Elevation Myocardial Infarction

05/06/2018

Chirag K. Desai¹, MD, Aiham Jbeli², MD, Tomasz Stys³, MD,
Adam Stys³, MD, FACC

Chirag K. Desai1, MD, Aiham Jbeli2, M...

We present a case of a patient diagnosed with very late stent ‘thrombosis’ (VLST) that may have been caused by hyperplastic tissue versus progressive atherosclerosis and late plaque rupture, despite chronic immunosuppressant use.

We present a case of a patient...

05/06/2018

Cath Lab Digest

CRF-SKIRBALL Interventional Innovation Corner

Bioresorbable Vascular Scaffolds

01/31/2016

The Skirball Center for Innovation (SCI) at the Cardiovascular Research Foundation (CRF) Interventional Innovation Corner is headed by section editor Juan F. Granada, MD, Executive Director and Chief Innovation Officer; Assistant Professor of Medicine, Columbia University College of Physicians and Surgeons, New York City, New York.

This month, Antonio Colombo, MD, Director of Cardiovascular Interventions at San Raffaele Scientific Institute, Columbus Hospital, Milan, Italy, shares his thoughts and experience with bioresorbable vascular scaffolds.

The Skirball Center for Innovation (S...

Bioresorbable scaffolds (BRS) are emerging as an alternative approach to metallic DES due to their ability to mechanically support coronary arteries in the early phase post intervention, followed by complete absorption of the scaffold over...

Bioresorbable scaffolds (BRS)...

01/31/2016

Cath Lab Digest

Original Contribution

Angina Severity, Depression, and Response to Percutaneous Revascularization in Patients With Chronic Total Occlusion of Coronary Arteries

10/15/2015

Jeffrey T. Bruckel, MD, MPH¹; Farouc A. Jaffer, MD, PhD²; Cashel O‚ÄôBrien, BA²; Luke Stone, BA²; Eugene Pomerantsev, MD, PhD²; Robert W. Yeh, MD, MSc²

Jeffrey T. Bruckel, MD, MPH1; Farouc...

This study sought to quantify depression rates in patients referred for percutaneous coronary intervention (PCI) for chronic total occlusion (CTO), assess its relationship to baseline angina symptoms, and compare angina improvement after...

This study sought to quantify...

10/15/2015

Journal of Invasive Cardiology

Case Report

Bioresorbable Vascular Scaffolds in Anomalous and Tortuous Vessels Treated by Radial Approach

09/07/2015

G. Sengottuvelu, MD, DM, FSCAI, FRCP, Ravindran Rajendran, MD, DM, Department of Cardiology, Apollo Hospital, Chennai, India

G. Sengottuvelu, MD, DM, FSCAI, FRCP,...

We present two cases of complex anatomies treated using radial access where we have successfully deployed a bioresorbable vascular scaffold with a good outcome.

We present two cases of complex...

09/07/2015

Cath Lab Digest